26 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
8 Aug 24
Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
4:17pm
advancing multiple new targets and reported positive interim data from its lead investigational drug in an ongoing Phase 1 study of BHV-1300 … confirming both CNS penetration and biomarker engagement of inflammatory targets in humans. Regarding our anti-myostatin taldefgrobep alfa, we shared new
8-K
EX-99.1
BHVN
Biohaven Ltd.
9 May 24
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
4:14pm
profile of BHV-1300 and have multiple IND-enabling activities planned for several additional MoDEs directed at autoantibody-mediated disease targets over … the next couple of years. MoDEs represent a transformative technology to modulate the immune system and specifically degrade extracellular targets known
8-K
EX-99.1
BHVN
Biohaven Ltd.
29 Feb 24
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
4:16pm
for efficient and safe removal of circulating pathogenic targets; BHV-1300, is an IgG degrader
Reported on progress with BHV-1300: The Company has
8-K
EX-99.1
k3he1nrxqb2tl
8 Jan 24
Regulation FD Disclosure
7:30am
8-K
EX-99.1
zbqq9ft2dw
14 Nov 23
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
4:26pm
8-K
EX-99.1
73ar8i
27 Sep 23
Regulation FD Disclosure
6:58am
8-K
EX-99.1
6nodsaxyr kj2
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm
8-K
EX-99.1
p6lwk
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm
10-Q
i0bdob5b hdz1
9 Nov 22
Quarterly report
4:19pm
8-K
EX-99.1
6g3q0lbzdy2tmwi81
9 Nov 22
Biohaven LTD. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments
4:05pm
424B4
2qjtp
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
hmvopvo
20 Oct 22
IPO registration (amended)
10:00am
S-1
xp9rm9r6rjbcqh
18 Oct 22
IPO registration
4:03pm
DRS
jwa0ogp 3w4
11 Oct 22
Draft registration statement
12:00am